VMP 42038611000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ondansetron 4mg tablets
BNF code 0406000S0AAABAB
Virtual Therapeutic Moiety Ondansetron
Date identifier became valid 7 Jul 2023
Previous product identifier 322173001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ondansetron hydrochloride dihydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372487007
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ondansetron 4mg tablets (A A H Pharmaceuticals Ltd)
Ondansetron 4mg tablets (Alissa Healthcare Research Ltd)
Ondansetron 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
Ondansetron 4mg tablets (Bristol Laboratories Ltd)
Ondansetron 4mg tablets (Cipla EU Ltd)
Ondansetron 4mg tablets (Crescent Pharma Ltd)
Ondansetron 4mg tablets (Ennogen Healthcare International Ltd)
Ondansetron 4mg tablets (Medihealth (Northern) Ltd)
Ondansetron 4mg tablets (Milpharm Ltd)
Ondansetron 4mg tablets (Phoenix Healthcare Distribution Ltd)
Ondansetron 4mg tablets (Relonchem Ltd)
Ondansetron 4mg tablets (Sigma Pharmaceuticals Plc)
Ondansetron 4mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Ondansetron 4mg tablets 10 tablet
Ondansetron 4mg tablets 15 tablet
Ondansetron 4mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20241202000001, imported on 3rd December 2024 at 03:57:46.

Feedback